HedgeChatter

  • Home /
  • Tag Archives

CTIC

CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts

[at noodls] – SEATTLE, March 3, 2014 /PRNewswire/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, … moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is hiring next, click here to […]

March 3, 2014 Bystocknews , Comments Off on CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts read more

Cell Therapeutics draws put sale

moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on Cell Therapeutics draws put sale read more

Cell Therapeutics draws put sale

moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on Cell Therapeutics draws put sale read more

NICE Publishes Final Guidance on PIXUVRI® (pixantrone)

[at noodls] – SEATTLE, Feb. 27, 2014 /PRNewswire/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported that the National Institute for Health and Care Excellence (NICE), the independent body responsible … moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on NICE Publishes Final Guidance on PIXUVRI® (pixantrone) read more

Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014

[PR Newswire] – SEATTLE, Feb. 25, 2014 /PRNewswire/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its fourth quarter and full year 2013 financial results on Tuesday, March … moreView todays social media effects on CTICView the latest stocks trending across Twitter. Click to view dashboardSee who Cell is hiring next, click here […]

February 25, 2014 Bystocknews , Comments Off on Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 read more